Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Malabar Remedies Ltd
NSE: MALABARREMBSE: 540987Pharma Formulations
₹3,154.80
▲ 59.35 (+1.92%)
Profit & Loss
- FY22: 20,757
- FY23: 23,697
- FY24: 28,532
- FY25: 33,407
- FY26: 35,844
- FY22: 2,170
- FY23: 2,775
- FY24: 2,930
- FY25: 3,174
- FY26: 4,462
- FY22: ₹35.81
- FY23: ₹45.79
- FY24: ₹48.35
- FY25: ₹52.38
- FY26: ₹73.63
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue from operations | 20,757 | 23,697 | 28,532 | 33,407 | 35,844 |
| Operating expenses | 16,847 | 19,313 | 23,526 | 27,723 | 28,823 |
| Operating profit (EBITDA) | 3,910 | 4,384 | 5,006 | 5,684 | 7,021 |
| Other income | 133 | 420 | 266 | 296 | 609 |
| Depreciation | 775 | 649 | 858 | 1,216 | 1,097 |
| Interest | 375 | 455 | 507 | 532 | 584 |
| Profit before tax | 2,893 | 3,700 | 3,907 | 4,232 | 5,949 |
| Tax | 723 | 925 | 977 | 1,058 | 1,487 |
| Net profit | 2,170 | 2,775 | 2,930 | 3,174 | 4,462 |
| EPS (₹) | 35.81 | 45.79 | 48.35 | 52.38 | 73.63 |
| Dividend per share (₹) | 17.66 | 22.58 | 23.84 | 25.83 | 36.31 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 10 periods. Premium unlocks the full 10-year history. See Premium